Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain
Recruiting
Phase 1
Phase 2
Interventional Study
Endometriosis
Adenomyosis
Chronic Pelvic Inflammatory Disease
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 21 and older
- Sex
- Female
- Trial phase
- Phase 1/2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Staci Gruber, Ph.D. · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Despite recent increases in both medical and recreational cannabis use in the United States and globally, little research has been conducted to determine the potential applications for womens health. A variety of medical cannabis and hemp-derived products on the marketplace claim to hold efficacy for many womens health-related conditions, including gynecologic pain. This 7-day study of individuals…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Provides informed consent
* Sex assigned female at birth
* Capable of having menstrual cycles
* Aged 21+
* Endorses one of the following gynecologic pain conditions: endometriosis, adenomyosis, chronic pelvic inflammatory disease (PID)
* Stable medication/psychotherapy regimen…
Contacts